PHI with Macroprolactinoma
How does this condition affect your private health insurance?
A macroprolactinoma is a non-cancerous tumor (adenoma) of the pituitary gland, measuring 10 millimeters or larger. It secretes excessive amounts of the hormone prolactin, leading to hyperprolactinemia. This can cause a range of symptoms, including galactorrhea (milk production), menstrual irregularities or amenorrhea in women, decreased libido and erectile dysfunction in men, and infertility in both sexes. Due to its size, a macroprolactinoma can also exert pressure on surrounding structures, particularly the optic chiasm, resulting in visual field defects like bitemporal hemianopsia, and headaches. Diagnosis involves blood tests for prolactin levels and MRI of the pituitary gland. Treatment often involves dopamine agonists to shrink the tumor and reduce prolactin.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms often develop insidiously over months to years before diagnosis.
Duration of Illness (Lifetime)
Typically a chronic condition requiring long-term monitoring and often continuous medical therapy.
Cost of Treatment (Initial)
High, involving expensive diagnostic imaging (MRI), specialized blood tests, and initial medication costs.
Cost of Treatment (Lifetime)
Moderate to high, including ongoing medication, regular follow-up consultations, and periodic imaging.
Mortality Rate
Very low directly from the tumor itself, but complications from mass effect or rare surgical risks can exist.
Risk of Secondary Damages
High, including visual field deficits, hypopituitarism, osteoporosis, sexual dysfunction, and psychological impact due to hormonal imbalances.
Probability of Full Recovery
Moderate to high for symptom resolution and prolactin normalization with medical therapy, but the tumor often persists, requiring ongoing management.
Underlying Disease Risk
Very low, although rarely associated with genetic syndromes like Multiple Endocrine Neoplasia type 1 (MEN1).